2:I[5405,["405","static/chunks/405-c23a2c1f7fa3928b.js","639","static/chunks/app/pages/1/page-280b61f73236595f.js"],"Image"]
3:I[6146,[],""]
4:I[4411,[],""]
5:"$Sreact.suspense"
6:I[7256,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"KeyboardNavigation"]
7:I[5407,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"SlideNavigation"]
0:["DkpgZd6XOJjDaY981EGFp",[[["",{"children":["pages",{"children":["1",{"children":["__PAGE__",{}]}]}]},"$undefined","$undefined",true],["",{"children":["pages",{"children":["1",{"children":["__PAGE__",{},[["$L1",["$","div",null,{"className":"relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700","children":[["$","$L2",null,{"src":"https://static.abacusaicdn.net/images/ad1b9c07-b69b-4b4c-948e-84cc9a1161fe.jpg","alt":"Modern pharmaceutical research laboratory","fill":true,"className":"object-cover","style":{"filter":"brightness(0.4) saturate(0.8)"}}],["$","div",null,{"className":"relative z-10 flex flex-col items-center justify-center w-full h-full p-8","children":[["$","div",null,{"className":"bg-slate-900/95 backdrop-blur-sm border border-slate-700/50 rounded-2xl p-10 max-w-7xl mx-auto text-center shadow-2xl","children":[["$","h1",null,{"className":"text-7xl font-bold mb-4 bg-gradient-to-r from-blue-400 to-purple-400 bg-clip-text text-transparent","children":"Unloxcyt Market Survey"}],["$","h2",null,{"className":"text-5xl font-bold text-white mb-4","children":"Comprehensive Market Analysis of Cosibelimab-ipdl"}],["$","h3",null,{"className":"text-3xl text-gray-200 mb-8","children":"PD-L1 Inhibitor for Advanced Cutaneous Squamous Cell Carcinoma"}],["$","p",null,{"className":"text-2xl text-gray-300 mb-2","children":"Checkpoint Therapeutics | Sun Pharmaceutical Industries"}],["$","p",null,{"className":"text-2xl text-blue-400 mb-8","children":"November 2025"}],["$","p",null,{"className":"text-base text-gray-400","children":"Prepared By: Strategic Market Intelligence"}]]}],["$","div",null,{"className":"absolute bottom-8 left-1/2 transform -translate-x-1/2","children":["$","p",null,{"className":"text-base text-gray-400/60","children":"Confidential | Strategic Analysis"}]}]]}]]}],null],null],null]},[null,["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children","1","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[null,["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/8d323862949ffad9.css","precedence":"next","crossOrigin":"$undefined"}]],["$","html",null,{"lang":"en","className":"dark","children":["$","body",null,{"className":"__className_f367f3 h-1080px w-1920px","children":[["$","$5",null,{"fallback":null,"children":[["$","$L6",null,{}],["$","$L7",null,{}]]}],["$","$L3",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":"404"}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],"notFoundStyles":[]}]]}]}]],null],null],["$L8",null]]]]
8:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Unloxcyt Market Survey - Interactive Presentation"}],["$","meta","3",{"name":"description","content":"Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC"}],["$","meta","4",{"name":"next-size-adjust"}]]
1:null
